Reported 852,150 shares, up 513,034 (151.3%) from the prior quarter.
Reported value 343.0%; share count 151.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-12-31 | 4030886 |
| 2026-03-31 | 6894228 |
| 2026-06-30 | 30541056 |
| 2026-09-30 | 3195441 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 313,586 | -538,564 (-63.2%) | < 0.01% | $3,195,441 | 2026-11-12 | |
| Q2 2026 | Added | 852,150 | +513,034 (151.3%) | < 0.01% | $30,541,056 | 2026-08-07 | |
| Q1 2026 | Added | 339,116 | +109,632 (47.8%) | < 0.01% | $6,894,228 | 2026-05-15 | |
| Q4 2025 | New | 229,484 | +229,484 (0.0%) | < 0.01% | $4,030,886 | 2026-02-13 |
Who else reported the position
115 managers reported MAPLIGHT THERAPEUTICS INC for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Novo Holdings A S | Unchanged | 3,686,622 | 0 | 7.67% | $132,128,532 | 3 qtrs |
| FCPM III SERVICES B V | Unchanged | 3,226,400 | 0 | 15.41% | $115,634,176 | 3 qtrs |
| T Rowe Price Investment Management Inc | Reduced | 2,781,728 | -20,209 | 0.07% | $99,698,000 | 3 qtrs |
| The Goldman Sachs Group Inc | Reduced | 1,948,312 | -46,561 | < 0.01% | $69,827,502 | 3 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 1,422,935 | +1,310,227 | < 0.01% | $50,999,000 | 2 qtrs |
| BlackRock Inc | Reduced | 1,025,134 | -314,597 | < 0.01% | $36,740,802 | 3 qtrs |
| Nan Fung Group Holdings Ltd | Unchanged | 971,253 | 0 | 26.47% | $34,809,708 | 3 qtrs |
| 5AM Venture Management LLC | Unchanged | 950,011 | 0 | 11.83% | $34,048,394 | 3 qtrs |
| Sanofi | Unchanged | 912,041 | 0 | 6.12% | $32,687,549 | 3 qtrs |
| STATE STREET CORPORATION This report | Added | 852,150 | +513,034 | < 0.01% | $30,541,056 | 3 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 07, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 91,702
- Shared
- 0
- None
- 760,448
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.